Tue 23'rd May 2017
Agile Therapeutics Stock Analysis
Technical stock analysis for Tue 23'rd May 2017
Buy candidate since 2017-05-23
Agile Therapeutics lies in the lower part of a very wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at USD 3.27 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 46.8% during the next 3 months and, with 90% probability hold a price between USD 4.80 and USD 6.38 at the end of this period.
Only positive signals in the chart today. Agile Therapeutics holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately USD 3.41. On a fall, the stock will find some support from the long-term average at approximately USD 3.27. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. A buy signal was issued from a pivot bottom point on Monday May 22, 2017, which indicates further gains until a new top pivot has been found. Agile Therapeutics has rising volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.
Relative Strength Index (RSI)
RSI14 is 41 and the stock is currently not being overbought or oversold
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at USD 2.96 and USD 2.94. On the upside the stock meets some resistance just above today's level from accumulated volume at USD 3.49, USD 3.59 and USD 3.47.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Agile Therapeutics finds support just below today's level at 2.96. If this is broken, then the next support from accumulated volume will be at 2.94 and 2.69. The stock is about to test the resistance from accumulated volume at USD 3.49 and this may cause the stock to take a minor break or get into a more sideways move for a few days.
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved USD 0.16 (4.80%) between high and low. For the last week, the stock has had a daily average volatility of 5.75%.
Our recommended stoploss: USD 3.15 (-6.34%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. We have upgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Buy Candidate.